Market Cap | ₹26,678Cr |
ROE | 1.12% |
P/E Ratio(TTM) | 290.87 |
EPS(TTM) | 0.69 |
P/B Ratio | 3.28 |
Dividend Yield | 0.07% |
Industry P/E | 35.11 |
Book Value | 61.17 |
Debt to Equity | 0.60 |
Face Value | 10 |
Parent Organisation | Piramal Pharma |
NSE Symbol | PPLPHARMA |
FUND NAME | AUM(%) |
---|---|
HDFC Focused Fund Direct Growth | 2.53% |
HDFC Flexi Cap Direct Plan Growth | 2.30% |
HSBC Midcap Fund Direct Growth | 1.17% |
Canara Robeco Small Cap Fund Direct Growth | 1.12% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 36.51 | ||
Cipla | NA (0.00%) | 22.63 | ||
Dr Reddy's Laboratories | NA (0.00%) | 18.58 | ||
Mankind Pharma | NA (0.00%) | 52.72 |